Cargando…

MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?

Introduction: Carcinomas represent a small percentage (0.1-0.2%) of all pituitary tumours. Several histological, immunocytochemical and ultrastructural characteristics are currently used to classify these tumors. Proliferation and invasion were proposed as prognostic markers. A Ki‐67 proliferation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Maria João, Salazar, Cristina, Costa, Cláudia, Gonçalves, Vanessa, Belo, Sandra, Pedro, Jorge, Freitas, Paula, Castedo, Jose Luis, Pereira, Josué, Silva, Roberto, Osório, Lígia, Vinha, Eduardo, Carvalho, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550949/
http://dx.doi.org/10.1210/js.2019-MON-417
_version_ 1783424300595806208
author Ferreira, Maria João
Salazar, Cristina
Costa, Cláudia
Gonçalves, Vanessa
Belo, Sandra
Pedro, Jorge
Freitas, Paula
Castedo, Jose Luis
Pereira, Josué
Silva, Roberto
Osório, Lígia
Vinha, Eduardo
Carvalho, Davide
author_facet Ferreira, Maria João
Salazar, Cristina
Costa, Cláudia
Gonçalves, Vanessa
Belo, Sandra
Pedro, Jorge
Freitas, Paula
Castedo, Jose Luis
Pereira, Josué
Silva, Roberto
Osório, Lígia
Vinha, Eduardo
Carvalho, Davide
author_sort Ferreira, Maria João
collection PubMed
description Introduction: Carcinomas represent a small percentage (0.1-0.2%) of all pituitary tumours. Several histological, immunocytochemical and ultrastructural characteristics are currently used to classify these tumors. Proliferation and invasion were proposed as prognostic markers. A Ki‐67 proliferation index of ≥3%, as well as strong and diffuse immunopositivity to p53 and invasion of surrounding structures are associated with aggressive clinical behaviour, although no clear morphological difference or specific biomarkers can conclusively differentiate adenomas from pituitary carcinomas. Case: 68 years-old man presented to our department with diplopia, palpebral ptosis, decreased visual acuity, increased weight and easy bruising. On physical exam he presented anisocoria L>R, mild left ptosis and hyperpigmentation. MRI revealed a macroadenoma invading the left cavernous sinus and with posterior growth. The patient underwent transphenoidal surgery resection and the biopsy showed a Ki-67 index of 25%, marked p53 positivity and high mitotic activity. After radiosurgery he was treated with 17 cycles of temozolamide without significant clinical response, then treatment with ketoconazole was initiated and later, in association, pasireotide. The patient developed hepatic dysfunction, with midnight serum cortisol of 73.1 μg/dL (n 1.7-8.9 μg/dL), midnight salivary cortisol of 4910 μg/dL (n <0.320), morning cortisol 69.9 μg/dL (n 6.2-19,4 μg/dL) and ACTH 290.5 ng/L (n <63.3ng/L). Sodium and potassium levels remained within the normal range. An abdominal CT scan showed a hypodense hepatic lesion, with a hypercaptive ring measuring 25 mm and a nodule in the lower lobe of the right lung, suggestive of metastatic lesions. An octreoscan was performed but did not reveal any pathological uptake. The patient underwent liver biopsy which revealed hepatic involvement by a carcinoma with ACTH expression, compatible with pituitary metastasis. Meanwhile metyrapone was initiated with clinical and analytical improvement. Conclusion: The invasive behaviour, a Ki-67 ≥ 10%, strong p53 immunopositivity and high mitotic activity have been proposed as strong predictors of pituitary carcinoma. New data is needed and future research should focus on early identification of this type of tumours in order to improve treatment and prognosis of these patients.
format Online
Article
Text
id pubmed-6550949
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65509492019-06-13 MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma? Ferreira, Maria João Salazar, Cristina Costa, Cláudia Gonçalves, Vanessa Belo, Sandra Pedro, Jorge Freitas, Paula Castedo, Jose Luis Pereira, Josué Silva, Roberto Osório, Lígia Vinha, Eduardo Carvalho, Davide J Endocr Soc Neuroendocrinology and Pituitary Introduction: Carcinomas represent a small percentage (0.1-0.2%) of all pituitary tumours. Several histological, immunocytochemical and ultrastructural characteristics are currently used to classify these tumors. Proliferation and invasion were proposed as prognostic markers. A Ki‐67 proliferation index of ≥3%, as well as strong and diffuse immunopositivity to p53 and invasion of surrounding structures are associated with aggressive clinical behaviour, although no clear morphological difference or specific biomarkers can conclusively differentiate adenomas from pituitary carcinomas. Case: 68 years-old man presented to our department with diplopia, palpebral ptosis, decreased visual acuity, increased weight and easy bruising. On physical exam he presented anisocoria L>R, mild left ptosis and hyperpigmentation. MRI revealed a macroadenoma invading the left cavernous sinus and with posterior growth. The patient underwent transphenoidal surgery resection and the biopsy showed a Ki-67 index of 25%, marked p53 positivity and high mitotic activity. After radiosurgery he was treated with 17 cycles of temozolamide without significant clinical response, then treatment with ketoconazole was initiated and later, in association, pasireotide. The patient developed hepatic dysfunction, with midnight serum cortisol of 73.1 μg/dL (n 1.7-8.9 μg/dL), midnight salivary cortisol of 4910 μg/dL (n <0.320), morning cortisol 69.9 μg/dL (n 6.2-19,4 μg/dL) and ACTH 290.5 ng/L (n <63.3ng/L). Sodium and potassium levels remained within the normal range. An abdominal CT scan showed a hypodense hepatic lesion, with a hypercaptive ring measuring 25 mm and a nodule in the lower lobe of the right lung, suggestive of metastatic lesions. An octreoscan was performed but did not reveal any pathological uptake. The patient underwent liver biopsy which revealed hepatic involvement by a carcinoma with ACTH expression, compatible with pituitary metastasis. Meanwhile metyrapone was initiated with clinical and analytical improvement. Conclusion: The invasive behaviour, a Ki-67 ≥ 10%, strong p53 immunopositivity and high mitotic activity have been proposed as strong predictors of pituitary carcinoma. New data is needed and future research should focus on early identification of this type of tumours in order to improve treatment and prognosis of these patients. Endocrine Society 2019-04-30 /pmc/articles/PMC6550949/ http://dx.doi.org/10.1210/js.2019-MON-417 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Neuroendocrinology and Pituitary
Ferreira, Maria João
Salazar, Cristina
Costa, Cláudia
Gonçalves, Vanessa
Belo, Sandra
Pedro, Jorge
Freitas, Paula
Castedo, Jose Luis
Pereira, Josué
Silva, Roberto
Osório, Lígia
Vinha, Eduardo
Carvalho, Davide
MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
title MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
title_full MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
title_fullStr MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
title_full_unstemmed MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
title_short MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
title_sort mon-417 is there a cut-off of ki-67 indicative of pituitary carcinoma?
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550949/
http://dx.doi.org/10.1210/js.2019-MON-417
work_keys_str_mv AT ferreiramariajoao mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT salazarcristina mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT costaclaudia mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT goncalvesvanessa mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT belosandra mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT pedrojorge mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT freitaspaula mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT castedojoseluis mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT pereirajosue mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT silvaroberto mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT osorioligia mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT vinhaeduardo mon417isthereacutoffofki67indicativeofpituitarycarcinoma
AT carvalhodavide mon417isthereacutoffofki67indicativeofpituitarycarcinoma